Explorer les evidences

Three sub-Saharan African countries — Ghana, Kenya, and Malawi — participated in a large-scale clinical study supervised by the WHO to assess the feasibility of vaccination against malaria in children.

Ghana · Kenya · MalawipaludismeHAL · Unilimdocument de 84 observations

2,6 %The period-prevalence of eczema was 2.6% in one Ghanaian study.

Ghanaeczemapublié 2012Journal of the European Academy of Dermatology and Venereology : JEADVeurope_pmcdocument de 10 observations

56,7 %Overall, 56.7% of the participants were hypertensive.

Ghana · Nigeriahypertension artériellepublié 2021Journal of clinical hypertension (Greenwich, Conn.)PubMeddocument de 2 observations

100 %The sensitivity of the GJB2-p.Arg143Trp NciI-RFLP testing was 100% in 111 individuals with isolated non-syndromic HI previously Sanger sequenced.

Ghananon-syndromic hearing impairmentpublié 2020Geneseurope_pmcdocument de 3 observationsDOI 10.3390/genes11020132

11 097 patientsA total of 11,097 patients were screened for confirmed uncomplicated malaria in an observational study conducted in Burkina Faso, Ghana, Mozambique, and Tanzania between September 2013 and April 2014.

Burkina Faso · Ghana · Mozambique · Tanzaniepaludismeobservé September 2013 to April 2014publié 2016Malaria journaleurope_pmcdocument de 6 observations

280 confirmed_casesFrom 1 January to 31 July 2025, 280 confirmed, 4,898 suspected, and 93 deaths (case fatality rate: 1.8%) of cholera were reported from four countries in the Western Africa region: Ghana, Côte d’Ivoire, Nigeria and Togo.

Ghana · Nigeria · Togocholéraobservé 1 January to 31 July 2025Africa CDCdocument de 176 observations

862 patientsHealth records of 862 patients with breast cancer were analysed across six tertiary care institutions in Ghana, Kenya, and Nigeria.

Ghana · Kenya · Nigeriacancer du seinobservé 2014 to 2017publié 2021BMJ openPubMeddocument de 13 observations

3 monthsThe average age at diagnosis of sickle cell disease was 3 months in Ghana.

Ghanadrépanocytosepublié 2025EJHaemeurope_pmcdocument de 7 observations

Obesity prevalence among Ghanaian migrants and Ghanaians living in Ghana is shown as age-standardised prevalence of obesity (BMI ≥30 kg/m2) by locality in men and women.

GhanaobésitéHAL · Unilimdocument de 3 observations

32 %Dans l’étude SIREN, 32 % des AVC étaient des hématomes.

Ghana · NigerAVCobservé 28 août 2014–15 juin 2017HAL · Unilimdocument de 570 observations

4 %The positive predictive value to identify eczema cases based on questionnaires compared to physical examination was 4% in the second Ghanaian study.

Ghanaeczemapublié 2012Journal of the European Academy of Dermatology and Venereology : JEADVeurope_pmcdocument de 10 observations

14,8 %An obstructive lung function pattern was observed in 14.8% (n = 17) of children with sickle cell disease compared to 5.2% (n = 6) of controls.

GhanadrépanocytosePubMeddocument de 6 observations

1,25 DALYsEach case of Guillain-Barré syndrome due to Zika virus infection results in a loss of 1.25 Disability-Adjusted Life Years (DALYs).

GhanaGuillain-Barré syndromeHAL · Unilimdocument de 40 observations

30 fold_increaseOver the last 50 years the incidence of mosquito-transmitted dengue has grown more than 30-fold.

Ghanadengueobservé last 50 yearsHAL · Unilimdocument de 40 observations

10,9 per_1000_follow_up_yearsThe incidence rate of diabetes-related lower limb amputation was 10.9% per 1000 follow-up years in Ghana in 2015.

Ghanadiabetes-related lower limb amputationobservé 2015publié 2019BMC endocrine disorderseurope_pmcdocument de 5 observations

38 %In a phase 2b trial in Ghana and Kenya, vaccine efficacy of the RTS,S malaria vaccine against clinical malaria (all episodes) at month 32 post-dose 1 ranged from 38% (95% confidence interval: 24%–49%) to 53% (95% confidence interval: 42%–62%).

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

74,7 %In Ghana, prevalence of hemoglobin genotypes was 74.7% for AA, 14.7% for AC, 9.1% for AS, and 0.9% for SS.

GhanapaludismeHAL · Unilimdocument de 81 observations

280 confirmed_casesFrom 1 January to 31 July 2025, 280 confirmed, 4,898 suspected, and 93 deaths (case fatality rate: 1.8%) of cholera were reported from Ghana, Côte d’Ivoire, Nigeria, and Togo in the Western Africa region.

Ghana · Nigeria · Togocholéraobservé 1 January to 31 July 2025Africa CDCdocument de 176 observations

7,12 nMArtemether was less potent against Plasmodium malariae than Plasmodium falciparum in Ghana, with IC50 values of 7.12 nM versus 2.15 nM.

Ghanapaludismepublié 2025Microbiology spectrumeurope_pmcdocument de 5 observations

73 500 000 USDThe National Dengue Vector Control Programme in Malaysia cost USD 73.5 million, which is 0.03% of Gross Domestic Product (GDP), from 2007 to 2012.

Ghanadengueobservé 2007 to 2012HAL · Unilimdocument de 40 observations

24,3 %A restrictive lung function pattern was observed in 24.3% (n = 28) of children with sickle cell disease compared to 12.2% (n = 14) of controls.

GhanadrépanocytosePubMeddocument de 6 observations

2 112 cases_averted_per_1000_childrenIn a phase 2b trial in Ghana and Kenya, vaccine impact of the RTS,S malaria vaccine, measured as cumulative number of clinical malaria cases averted per 1000 children vaccinated at month 32 post-dose 1, was 2112 for group Fx017-20-32.

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

84,9 %A silhouette ≥ 5 had sensitivity of 84.9% to predict BMI ≥ 25 kg/m² in Ghana.

Ghanaobésitépublié 2020Utility of silhouette showcards to assess adiposity in three countries across the epidemioeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-46029/v1

12,7 %Plasmodium malariae was detected in 12.7% of the 142 malaria-positive participants in Mpraeso, Ghana.

Ghanapaludismeobservé 2014publié 2017Malaria journalPubMeddocument de 4 observations

34 406 casesGhana had 34,406 confirmed SARS-CoV-2 cases as of 29 July 2020.

GhanaCOVID-19observé 29 July 2020HAL · Unilimdocument de 97 observations